本页面由Tiger Trade Technology Pte. Ltd.提供服务

Capricor Therapeutics Inc

26.02
-1.1600-4.27%
盘后25.90-0.1200-0.46%17:40 EST
成交量:178.26万
成交额:4,681.45万
市值:13.46亿
市盈率:-14.41
高:27.12
开:26.55
低:25.59
收:27.18
52周最高:40.37
52周最低:4.30
股本:5,171.85万
流通股本:4,618.69万
量比:0.49
换手率:3.86%
股息:- -
股息率:- -
每股收益(TTM):-1.8055
每股收益(LYR):-1.1490
净资产收益率:-107.79%
总资产收益率:-49.39%
市净率:16.05
市盈率(LYR):-22.65

数据加载中...

公司资料

公司名字:
Capricor Therapeutics Inc
交易所:
NASDAQ
成立时间:
2005
员工人数:
160
公司地址:
10865 Road to the Cure,Suite 150,San Diego,California,United States
邮编:
92121
电话:
传真:
- -
简介:
Capricor Therapeutics, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,专注于开发基于转化细胞和外泌体的疗法,用于治疗Duchenne肌营养不良症(“DMD”),这是一种罕见的导致肌肉退化和过早死亡的肌营养不良症,以及具有高度未满足的医疗需求的疾病。

董事

名称
职位
Frank Litvack
Executive Chairman and Director
Linda Marban
President, Chief Executive Officer and Director
David B. Musket
董事
Earl M. Collier, Jr.
董事
George W. Dunbar, Jr.
董事
Joshua A. Kazam
董事
Louis Manzo
董事

股东

名称
职位
Linda Marban
President, Chief Executive Officer and Director
Leland Gershel
Chief Financial Officer and Principal Financial Officer
Anthony Bergmann
Vice President of Finance and Principal Accounting Officer
Deborah Ascheim
Chief Medical Officer
Karen G. Krasney
Executive Vice President and General Counsel
Rachel Smith
Vice President of Research and Development